Xylem Inc. (XYL)
StalwartFairStock Score: 48/100 — MIXED
Key Financials
| Current Price | $108.12 |
| Market Cap | $29.9B |
| P/E Ratio | 26.9 |
| ROE | 8.72% |
| Dividend Yield | 1.56% |
| Sector | Industrials |
Strengths
- Essential business model focused on critical water infrastructure with long-term secular tailwinds
- Solid free cash flow generation of $893M annually with fortress balance sheet (D/E 0.21)
- Diversified across four segments serving utility, industrial, and commercial markets globally
- Respectable net margin of 14% in latest quarter demonstrates operational discipline
- Altman Z-Score of 3.67 indicates strong financial stability and low bankruptcy risk
Concerns
- Alarmingly low return metrics: ROCE of 4.83% and ROE of 8.4% indicate capital is not being deployed efficiently
- Valuation appears stretched at 30.8x P/E and 58.92x EV/EBITDA for a low-ROCE industrial company
- Deteriorating financial quality signaled by Piotroski F-Score of only 6/9
- Insufficient growth visibility with N/A figures for revenue and profit growth rates
AI Analysis
Xylem presents a classic case of a quality business trading at a quality price—which is to say, an expensive one. The company operates in essential water infrastructure, a secular growth tailwind backed by aging global water systems and climate concerns. With $2.4B in quarterly revenue and a respectable 14% net margin, Xylem generates meaningful cash flow at $893M annually. However, I find myself cautious. At 30.8x earnings with an EV/EBITDA of 58.92x, we're paying premium prices for what amounts to mid-single-digit returns on capital. The ROCE of 4.83% and ROE of 8.4% are genuinely concerning—these are below cost of capital for most investors. The Piotroski F-Score of 6/9 suggests deteriorating financial quality, not improving. Yes, the balance sheet is solid with a D/E ratio of 0.21, and the FCF generation is legitimate. But I cannot ignore that we're buying a structurally mediocre business at an exceptional valuation. The 52-week high of $154 now seems prescient; at $122.71, we're merely at the edge of reasonable, not in deep value territory. Growth visibility remains unclear with N/A figures on revenue and profit growth rates. For Graham, this would fail the margin of safety test. For Buffett, the low ROCE would disqualify it immediately. I'd wait for better entry points or seek higher-quality industrials trading more reasonably.
Bull Case
Global water scarcity and aging infrastructure present a multi-decade growth opportunity, with Xylem positioned as a premier solution provider. The company's solid cash generation and low leverage provide flexibility to invest in innovation and acquisitions, potentially improving returns over time.
Bear Case
At current valuations, the market is pricing in significant future growth that may not materialize given historical low returns on capital. Macro slowdown could pressure demand while investors may demand valuation compression as ROCE fails to improve materially.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer